Targeted therapy like rituximab (a type of immunotherapy) can be used in marginal zone lymphoma when initial treatments haven't provided a complete response. Rituximab works by targeting specific proteins on B-cells to help destroy cancer cells.
This treatment may be used alone or combined with chemotherapy for better Show Full Answer
Targeted therapy like rituximab (a type of immunotherapy) can be used in marginal zone lymphoma when initial treatments haven't provided a complete response. Rituximab works by targeting specific proteins on B-cells to help destroy cancer cells.
This treatment may be used alone or combined with chemotherapy for better results. It's particularly effective because it's engineered to recognize specific antigens on the surface of B cells, making it a precise treatment option. Newer targeted treatments, such as BTK inhibitors, are also becoming available, particularly for patients with relapsed or refractory disease. These newer options are helping to improve treatment outcomes. It's important to discuss with your healthcare team about when targeted therapy might be most appropriate for your specific situation.
May 15, 2025
Join
Your Privacy Choices
